Month: March 2018
Recent Posts
- ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
- ARCA biopharma Provides Update Regarding Special Dividend Amount in Connectionwith the Proposed Merger with Oruka Therapeutics
- ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
- ARCA biopharma Declares Special Dividend in Connection with the Proposed Mergerwith Oruka Therapeutics
- ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Archives
- August 2024
- April 2024
- February 2024
- October 2023
- July 2023
- April 2023
- March 2023
- December 2022
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- May 2021
- March 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- February 2020
- November 2019
- September 2019
- August 2019
- May 2019
- April 2019
- March 2019
- February 2019
- December 2018
- November 2018
- September 2018
- August 2018
- July 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- November 2017
- September 2017
- August 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- November 2016
- October 2016
- August 2016
- May 2016
- April 2016
- March 2016
- January 2016
- November 2015
- September 2015
- August 2015
- June 2015